New approaches to control infections: anti-biofilm strategies against gram-negative bacteria.
dc.contributor.author | Sommer, Roman | |
dc.contributor.author | Joachim, Ines | |
dc.contributor.author | Wagner, Stefanie | |
dc.contributor.author | Titz, Alexander | |
dc.date.accessioned | 2014-12-05T09:59:07Z | |
dc.date.available | 2014-12-05T09:59:07Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | New approaches to control infections: anti-biofilm strategies against gram-negative bacteria. 2013, 67 (4):286-90 Chimia (Aarau) | en |
dc.identifier.issn | 0009-4293 | |
dc.identifier.pmid | 23967708 | |
dc.identifier.uri | http://hdl.handle.net/10033/336700 | |
dc.description.abstract | Hospital-acquired bacterial infections, especially with Gram-negative pathogens, present a major threat due to the rapid spread of antibiotic-resistant strains. Targeting mechanisms of bacterial virulence has recently appeared as a promising new therapeutic paradigm. Biofilm formation is a bacterial lifestyle, which offers a survival advantage through its protective matrix against host immune defense and antibiotic treatment. Interfering with biogenesis of adhesive organelles, bacterial communication or carbohydrate-mediated adhesion as anti-biofilm strategies are reviewed. | |
dc.language.iso | en | en |
dc.subject.mesh | Anti-Bacterial Agents | en |
dc.subject.mesh | Biofilms | en |
dc.subject.mesh | Cross Infection | en |
dc.subject.mesh | Gram-Negative Bacteria | en |
dc.subject.mesh | Gram-Negative Bacterial Infections | en |
dc.subject.mesh | Humans | en |
dc.title | New approaches to control infections: anti-biofilm strategies against gram-negative bacteria. | en |
dc.type | Article | en |
dc.contributor.department | University of Konstanz, Department of Chemistry and Zukunftskolleg, Universitätsstrasse 10, D-78457 Konstanz. | en |
dc.identifier.journal | Chimia | en |
refterms.dateFOA | 2018-06-13T21:23:47Z | |
html.description.abstract | Hospital-acquired bacterial infections, especially with Gram-negative pathogens, present a major threat due to the rapid spread of antibiotic-resistant strains. Targeting mechanisms of bacterial virulence has recently appeared as a promising new therapeutic paradigm. Biofilm formation is a bacterial lifestyle, which offers a survival advantage through its protective matrix against host immune defense and antibiotic treatment. Interfering with biogenesis of adhesive organelles, bacterial communication or carbohydrate-mediated adhesion as anti-biofilm strategies are reviewed. |